Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Scopolamine
(D02071)		1件: Scopolamine2件: Scopolamine ,
Scopolamine hydrobromide (D02071) 💬 		5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 2 💬
2Scopolamine, atropine, edaravone and dexmedetomidine
(D02071)		4件: Atropine,
Dexmedetomidine,
Edaravone,
Scopolamine		7件: Atropine ,
Scopolamine ,
Dexmedetomidine ,
Dexmedetomidine hydrochloride ,
Edaravone ,
Atropine sulfate ,
Scopolamine hydrobromide (D02071) 💬 		8件: ADRA2A,
ADRA2B,
ADRA2C,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		16件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Hormone signaling, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2 💬